Cargando…

SMARCD3 is a potential prognostic marker and therapeutic target in CAFs

Objective: Screening for novel prognostic biomarkers and potential therapeutic targets from colorectal cancer microenvironment. Results: 372 genes were overexpressed in colorectal cancer microenvironment, five of which that had the most prognostic powers were enriched in Epithelial-Mesenchymal Trans...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Ming, Wang, Huiju, Chen, Hong, Han, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655158/ https://www.ncbi.nlm.nih.gov/pubmed/33125346 http://dx.doi.org/10.18632/aging.104102

Ejemplares similares

LncRNA SMARCD3-OT1 Promotes Muscle Hypertrophy and Fast-Twitch Fiber Transformation via Enhancing SMARCD3X4 Expression
por: Zhang, Jing, et al.
Publicado: (2022)

MBRS-63. THE ROLE OF THE SWI/SNF COMPLEX SUBUNIT SMARCD3 IN MEDULLOBLASTOMA
por: Poore, Brad, et al.
Publicado: (2020)

Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma
por: Ferguson, L. Paige, et al.
Publicado: (2023)

SMARCD1 regulates senescence-associated lipid accumulation in hepatocytes
por: Inoue, Chisato, et al.
Publicado: (2017)

PBRM1 presents a potential prognostic marker and therapeutic target in duodenal papillary carcinoma
por: He, Xujun, et al.
Publicado: (2022)

Comprehensive analysis of the association of EGFR, CALM3 and SMARCD1 gene polymorphisms with BMD in Caucasian women
por: Zhou, Qiu-Hong, et al.
Publicado: (2014)

Cancer-Associated Fibroblast (CAF) Heterogeneity and Targeting Therapy of CAFs in Pancreatic Cancer
por: Geng, Xinglong, et al.
Publicado: (2021)

Expression of SMARCD1 interacts with age in association with asthma control on inhaled corticosteroid therapy
por: McGeachie, Michael J., et al.
Publicado: (2020)

SMARCD1 negatively regulates myeloid differentiation of leukemic cells via epigenetic mechanisms
por: Saha, Subha, et al.
Publicado: (2022)

Smarcd1 Inhibits the Malignant Phenotypes of Human Glioblastoma Cells via Crosstalk with Notch1
por: Zhu, Yihao, et al.
Publicado: (2020)

Different Expression and Clinical Implications of Cancer-Associated Fibroblast (CAF) Markers in Brain Metastases
por: Akanda, Md Rashedunnabi, et al.
Publicado: (2023)

A neurodevelopmental epigenetic programme mediated by SMARCD3–DAB1–Reelin signalling is hijacked to promote medulloblastoma metastasis
por: Zou, Han, et al.
Publicado: (2023)

Challenging, Accurate and Feasible: CAF-1 as a Tumour Proliferation Marker of Diagnostic and Prognostic Value
por: Sykaras, Alexandros G., et al.
Publicado: (2021)

Intensive Glucose Control Reduces the Risk Effect of TRIB3, SMARCD3, and ATF6 Genetic Variation on Diabetic Vascular Complications
por: He, Fazhong, et al.
Publicado: (2018)

MEDB-88. BAF60C/SMARCD3-mediated novel neurodevelopmental epigenomic program promotes metastatic dissemination in medulloblastoma
por: Zou, Han, et al.
Publicado: (2022)

CAF-specific markers: role of the TGFβ pathway
por: Busch, Susann, et al.
Publicado: (2015)

Synergistic therapeutic combination with a CAF inhibitor enhances CAR-NK-mediated cytotoxicity via reduction of CAF-released IL-6
por: Lee, Young Eun, et al.
Publicado: (2023)

Congenital Neutropenia with Specific Granulocyte Deficiency Caused by Novel Double Heterozygous SMARCD2 Mutations
por: Ibrahim, Abukhiran, et al.
Publicado: (2022)

CEACAM6 is a prognostic biomarker and potential therapeutic target for gastric carcinoma
por: Ru, Guo-Qing, et al.
Publicado: (2017)

microRNA‐99a‐5p induces cellular senescence in gemcitabine‐resistant bladder cancer by targeting SMARCD1
por: Tamai, Motoki, et al.
Publicado: (2022)

Determination of Potential Therapeutic Targets and Prognostic Markers of Ovarian Cancer by Bioinformatics Analysis
por: Zhang, Jing, et al.
Publicado: (2021)

A new DNA marker CafLess-TCS1 for selection of caffeine-less tea plants
por: Ogino, Akiko, et al.
Publicado: (2019)

Identification of the novel therapeutic targets and biomarkers associated of prostate cancer with cancer-associated fibroblasts (CAFs)
por: Zhai, Xinyu, et al.
Publicado: (2023)

Aminoacylase 3 Is a New Potential Marker and Therapeutic Target in Hepatocellular Carcinoma
por: Tsirulnikov, Kirill, et al.
Publicado: (2018)

Eukaryotic elongation factor 2 is a prognostic marker and its kinase a potential therapeutic target in HCC
por: Pott, Leona L, et al.
Publicado: (2017)

Withdrawal: MicroRNA-7 compromises p53-dependent apoptosis by controlling the expression of the chromatin remodeling factor SMARCD1
por: Hong, Chun-Fu, et al.
Publicado: (2021)

HNRNPK/CLCN3 axis facilitates the progression of LUAD through CAF-tumor interaction
por: Li, Yixin, et al.
Publicado: (2022)

SWI/SNF Subunits SMARCA4, SMARCD2 and DPF2 Collaborate in MLL-Rearranged Leukaemia Maintenance
por: Cruickshank, V. Adam, et al.
Publicado: (2015)

Defective neutrophil development and specific granule deficiency caused by a homozygous splice-site mutation in SMARCD2
por: Schim van der Loeff, Ina, et al.
Publicado: (2021)

Long Noncoding RNA SBF2-AS1 Promotes Abdominal Aortic Aneurysm Formation through the miRNA-520f-3p/SMARCD1 Axis
por: Han, Baihe, et al.
Publicado: (2022)

The importance of being CAFs (in cancer resistance to targeted therapies)
por: Rizzolio, Sabrina, et al.
Publicado: (2022)

Tissue Microarray-Based Evaluation of Chromatin Assembly Factor-1 (CAF-1)/p60 as Tumour Prognostic Marker
por: Mascolo, Massimo, et al.
Publicado: (2012)

DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer
por: Song, L. J., et al.
Publicado: (2016)

Identification of Mutation Landscape and Immune Cell Component for Liver Hepatocellular Carcinoma Highlights Potential Therapeutic Targets and Prognostic Markers
por: Wang, Hengzhen, et al.
Publicado: (2021)

BRG1 Is a Prognostic Marker and Potential Therapeutic Target in Human Breast Cancer
por: Bai, Jin, et al.
Publicado: (2013)

Upregulated expression of Annexin II is a prognostic marker for patients with gastric cancer
por: Zhang, Qi, et al.
Publicado: (2012)

Functional screening of mammalian mechanosensitive genes using Drosophila RNAi library– Smarcd3/Bap60 is a mechanosensitive pro-inflammatory gene
por: Kumar, Sandeep, et al.
Publicado: (2016)

PTCDA adsorption on CaF(2) thin films
por: Rahe, Philipp
Publicado: (2020)

Sequentially targeting and intervening mutual Polo-like Kinase 1 on CAFs and tumor cells by dual targeting nano-platform for cholangiocarcinoma treatment
por: Zhou, Yue, et al.
Publicado: (2022)

Galectins as New Prognostic Markers and Potential Therapeutic Targets for Advanced Prostate Cancers
por: Laderach, Diego J., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_86269g32gk3hja8cf33e80houi